Myomo (MYO)
(Real Time Quote from BATS)
$3.78 USD
+0.02 (0.53%)
Updated Sep 5, 2024 01:36 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Myomo, Inc. (MYO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.30 | $8.50 | $6.00 | 94.15% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Myomo, Inc. comes to $7.30. The forecasts range from a low of $6.00 to a high of $8.50. The average price target represents an increase of 94.15% from the last closing price of $3.76.
Analyst Price Targets (5 )
Broker Rating
Myomo, Inc. currently has an average brokerage recommendation (ABR) of 1.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 80% and 20% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MYO.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 | 3 |
Buy | 1 | 1 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.20 | 1.20 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/19/2024 | Ascendiant Capital Markets | Edward M Woo | Not Available | Moderate Buy |
8/12/2024 | H.C. Wainwright & Co. | Sean Lee | Strong Buy | Strong Buy |
7/31/2024 | Craig-Hallum | Chase Knickerbocker | Not Available | Strong Buy |
5/20/2024 | Lake Street Capital Markets | Benjamin Haynor | Not Available | Strong Buy |
3/15/2024 | Maxim Group | Anthony V Vendetti | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.20 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 5 |
Average Target Price | $7.30 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -0.03 |